Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure

Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure

Item

http://www.wikidata.org/entity/Q33381364

Q33381364

about

Initial resuscitation and management of pediatric septic shock Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Multiple organ failure syndrome in the newborn: morphological and immunohistochemical data.Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome.Plasma exchange therapy for thrombotic microangiopathies.Thrombocytopenia-associated multiple organ failure or severe haemolysis, elevated liver enzymes, low platelet count in a postpartum case Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network.VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura.Thrombocytopenia-associated multiorgan failure occurring in an infant at the onset of type 1 diabetes successfully treated with fresh frozen plasma.Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome.The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis.Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support Therapeutic plasma exchange as a strategy to reverse multiple organ dysfunction syndrome in patients receiving extracorporeal life support.Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.THE ENDOTHELIUM IN SEPSIS.Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.The role of plasmapheresis in critical illness.Daily estimation of the severity of organ dysfunctions in critically ill children by using the PELOD-2 score Pediatric sepsis: challenges and adjunctive therapies.Decreased ADAMTS 13 Activity is Associated With Disease Severity and Outcome in Pediatric Severe Sepsis.Could Biomarkers Direct Therapy for the Septic Patient?Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome.Outcomes of previously healthy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange.Therapeutic apheresis in children: special considerations.Septic shock with multiorgan failure: from conventional apheresis to adsorption therapies.Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus.Randomized controlled trials in therapeutic apheresis.Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions.Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome.Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability.Outcomes in necrotizing soft tissue infections treated with therapeutic plasma exchange.[Plasma exchange in treatment refractory septic shock : Presentation of a therapeutic add-on strategy].

P2860

Q28083003-8EBAD61A-C575-4FCD-99C8-70F15A68847A Q30276550-0B25D609-AB3A-462A-8BBF-A0647AE1B71C Q30571550-E724D03A-1190-4647-AE20-E578E0653E69 Q33393302-D4B4D4D4-F1A2-4227-9604-02E9607BA093 Q33393983-91B05668-1385-40C1-B269-D96FF03A1BAC Q33408058-DB12FD83-8CF6-4E1F-90B4-140DEC7E7871 Q33411744-0C9D321B-3520-43D6-ACAE-A50267A7C0F7 Q33416769-B85C0B0E-F06C-4DD8-A041-04B29BB0275C Q33419324-CD231A0B-A29F-4B65-BC83-AB54A52B7130 Q33426245-40BD1D04-98F8-4968-89E8-59947DD04A4B Q33428178-41D761BF-2940-41BC-AED0-BF6CF3995C00 Q33433695-3D9BEC32-F47A-4F7F-B783-D5550BF0C0F9 Q33434503-412E05DE-3B6D-41CC-AB31-CE1B667884F8 Q33439759-179B2E58-BABA-4EB5-90E1-847FE371C1C5 Q33441000-74A979FB-B9C2-4512-9953-DA2284AF018C Q33751764-CFC1E1ED-9DBC-4EDF-A2B2-1F044B43EE0C Q34122035-FBC3D77B-61FD-4E9E-9AC5-58417B45ADF2 Q35052920-9304DFE7-CC46-4C83-BB95-D9241D8F3E61 Q35582172-723032DB-B6FB-4A8F-A3B0-D9E493D8B74E Q35586159-7ECFF530-2669-4A0B-B1FA-5B83220FED8A Q35672605-9B8EECDE-AF0E-4A83-89F5-6A784825BBCF Q35922159-C83B162A-7081-4C20-9AA4-FA9687A28460 Q35946802-4B58BE48-100E-4EFB-AC6B-944600497974 Q36053839-D8B403C9-48D5-4BF6-9745-16DCC9F8FAF8 Q36060518-9E3FCE1A-40BD-4D8D-A226-9F1734131787 Q36728513-4026CA2D-151C-4696-83C9-65E3CD46156E Q36838015-109BB6E5-7F25-4223-9FFC-2C66EB6535EA Q36852546-FA0C7FBB-65C1-42C1-9308-6AB3BB32ACE1 Q37119048-1E1BB080-CA27-4693-BFC7-BEEDA1F6AB5F Q37904925-C9A80DB3-286E-4C3E-99AB-8553CA032C9E Q37978684-E4465103-5E12-44DA-ABC0-F133A4181183 Q37983637-7056CBC4-C068-41B7-8E7C-A5F4D22414E1 Q37998979-226D3AE4-94D8-45A0-A0E8-D6D53E90E556 Q38078306-CA430447-6033-4B31-B664-F23944279A93 Q38263347-4580BE11-3B55-4B22-BAF8-9E164BA0502E Q38751931-D258B6AB-2E1A-4E3A-BF39-D4CA0E9FE09B Q38935733-FD795375-0244-4C4E-B939-98D88A64B0C1 Q39500397-69CBCFA6-F991-49B6-BB93-0137FD7CEF53 Q40305748-E16DBC08-1A20-41BD-B13E-B46AB3264430 Q40896290-761A4186-777C-4369-8497-1ED0A15E59AE

P2860

Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure

Item

http://www.wikidata.org/entity/Q33381364

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu